Cleared Traditional

K873382 - PLATELET EXTRACT REAGENT

K873382 is the FDA 510(k) clearance for PLATELET EXTRACT REAGENT by Bio/Data Corp.. It is a Class 2 Hematology device (product code GGW) cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K873382 · Bio/Data Corp. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1987
Decision
88d
Days
Class 2
Risk

K873382 is an FDA 510(k) clearance for the PLATELET EXTRACT REAGENT. Classified as Test, Time, Partial Thromboplastin (product code GGW), Class II - Special Controls.

Submitted by Bio/Data Corp. (Hatboro, US). The FDA issued a Cleared decision on November 20, 1987 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7925 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio/Data Corp. devices

Submission Details

510(k) Number K873382 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 24, 1987
Decision Date November 20, 1987
Days to Decision 88 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 113d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GGW Test, Time, Partial Thromboplastin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7925
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGW Test, Time, Partial Thromboplastin

All 20
Devices cleared under the same product code (GGW) and FDA review panel - the closest regulatory comparables to K873382.
PTT-LA TEST KIT
K921684 · American Bioproducts Co. · Jun 1992
ACTIVATED PARTIAL THROMBOPLASTIN TIME
K915463 · Sigma Diagnostics, Inc. · Jan 1992
READS ANTI-CARDIOLIPIN SEMI-QUANTITATIVE TEST KIT
K902236 · Biosearch Medical Products, Inc. · Aug 1990
ACTIN FSL ACTIVATED PTT REAGENT
K863594 · American Dade · Oct 1986
PTT AUTOMATE TEST KIT
K861190 · American Bioproducts Co. · Jun 1986
CITREX H
K853897 · Bio/Data Corp. · Oct 1985